CED has also been studied in pediatric patients with DIPG; a recent Phase I trial demonstrated the safety of IL13-Pseudomonas toxin infusion into the brainstem using this method [473]. This evidence concerns the gene IL13 and diffuse intrinsic pontine glioma.